Holen Sie sich die Stockscreener-App
0.1335
3.26%
-0.0045
Schlusskurs vom Vortag:
$0.138
Offen:
$0.136
24-Stunden-Volumen:
1.83M
Relative Volume:
1.33
Marktkapitalisierung:
$1.70M
Einnahmen:
$8.77M
Nettoeinkommen (Verlust:
$-19.05M
KGV:
-0.00208
EPS:
-64.1076
Netto-Cashflow:
$-11.60M
1W Leistung:
-4.64%
1M Leistung:
-86.36%
6M Leistung:
-93.82%
1J Leistung:
-52.13%
1-Tages-Spanne:
$0.1335
$0.143
1-Wochen-Bereich:
$0.1246
$0.1559
52-Wochen-Spanne:
$0.1246
$25.95
Nuwellis Inc Stock (NUWE) Company Profile
Firmenname
Nuwellis Inc
Sektor
Branche
Telefon
952-345-4200
Adresse
12988 VALLEY VIEW ROAD, EDEN PRAIRIE
Compare NUWE vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NUWE
Nuwellis Inc
|
0.1335 | 1.70M | 8.77M | -19.05M | -11.60M | -64.11 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Nuwellis Inc Stock (NUWE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-29 | Eingeleitet | ROTH MKM | Buy |
Nuwellis Inc Aktie (NUWE) Neueste Nachrichten
Nuwellis Inc (NUWE) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Nuwellis Inc (NUWE) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Nuwellis Inc (NUWE) Institutional Confidence - TradingKey
Nuwellis Inc (NUWE) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Nuwellis Inc (NUWE) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
symbol__ Stock Quote Price and Forecast - CNN
Nuwellis Inc (NUWE) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Nuwellis Appoints Mike McCormick as CEO to Drive Growth in Cardiorenal Medical Technology - Minichart
Nuwellis provides Aquadex training to 280 physicians at summit - Investing.com
Nuwellis (NUWE) Showcases Aquadex Technology at Critical Care Su - GuruFocus
Nuwellis Expands Critical Care Education with Aquadex Training at University of Minnesota Critical Care Cardiology Education Summit - The Manila Times
University of Minnesota summit puts 280 doctors on Aquadex hands-on - Stock Titan
Nuwellis Appoints Michael McCormick CEO Amid Leadership Transition - TipRanks
Nuwellis Inc (NUWE) Valuation: PE, PB & Fair Value Analysis - TradingKey
Nuwellis Inc (NUWE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Nuwellis Inc (NUWE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
New Nuwellis (NASDAQ: NUWE) CEO Mike McCormick to replace John Erb on June 30, 2026 - Stock Titan
Nuwellis names Mike McCormick as CEO - MSN
Nuwellis (NUWE) Appoints New CEO in Leadership Transition - GuruFocus
Nuwellis Hires Mike McCormick as CEO - Medical Product Outsourcing
Nuwellis appoints Mike McCormick as CEO effective June 30 By Investing.com - Investing.com South Africa
Nuwellis appoints Mike McCormick as CEO effective June 30 - Investing.com
Nuwellis names Mike McCormick as CEO effective June 30, 2026, with John Erb staying as Chairman. - Pluang
Nuwellis Appoints Mike Mccormick As Chief Executive Officer - TradingView
Nuwellis, Inc. Appoints Mike McCormick as Chief Executive Officer Effective June 30, 2026 - Quiver Quantitative
Nuwellis Appoints Mike McCormick as Chief Executive Officer - The Manila Times
Press Release: Nuwellis Appoints Mike McCormick as Chief Executive Officer - Moomoo
NUWE Q1 2026 Earnings: EPS Misses Estimates by Over 100%, Shares Edge HigherAnalyst Drop Coverage - newsline.com
NUWE Q1 2026 Earnings: Significant EPS Miss Amid Missing Revenue DataTax Rate Impact - newsline.com
Nuwellis (NUWE) Slips 7.9% as Shares Test Key Support at $0.13Box Spread - newsline.com
Nuwellis shares sink after pricing $6 million equity and warrant offering (NUWE) - MSN
Nuwellis expands pediatric ultrafiltration partnership in S.C. By Investing.com - Investing.com South Africa
Nuwellis expands use of Aquadex SmartFlow® devices in South Carolina pediatric hospitals - Pluang
Nuwellis (NUWE) Expands Collaboration with South Carolina Health - GuruFocus
Nuwellis closes $6.0M registered offering, issues pre-funded warrants and Series C/D warrants - TradingView
Nuwellis (NASDAQ: NUWE) raises $6.0M in stock, pre-funded warrant and new warrant deal - Stock Titan
Nuwellis expands pediatric ultrafiltration partnership in S.C. - Investing.com
Nuwellis Expands Collaboration with Major South Carolina Healthcare System to Install New Aquadex SmartFlow® Devices at One of its Children’s Hospitals - The Manila Times
Children’s hospital adds Aquadex as Nuwellis readies pediatric FDA filing - Stock Titan
Nuwellis closes $6 million public offering with warrants By Investing.com - Investing.com India
Nuwellis closes $6M public offering to fund growth in cardiorenal medical tech. - Pluang
Nuwellis closes $6 million public offering with warrants - Investing.com UK
Nuwellis closes $6M public offering to fund cardiorenal medical tech development - Pluang
Nuwellis, Inc. Closes Public Offering Raising Approximately $6.0 Million - Quiver Quantitative
Medical technology firm prices $0.30 stock in $6M offering - Stock Titan
Nuwellis Announces Closing of $6.0 Million Registered Public Offering - The Manila Times
Nuwellis Announces Closing of $6.0 Million Registered Public Offering - Benzinga
Nuwellis (NASDAQ: NUWE) offers shares, pre-funded warrants and large warrant pool - Stock Titan
NUWE Q1 2026 Earnings: Wider-than-Expected Loss Sends Shares Down SharplyRevenue Miss Report - newsline.com
Nuwellis prices $6M public offering of 20M shares with warrants at $0.30 each - Pluang
Nuwellis prices $6 million public offering at $0.30 per share - Investing.com UK
Finanzdaten der Nuwellis Inc-Aktie (NUWE)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.93%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):